We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byNasir Corson
Modified about 1 year ago
Copyright © 2014 American Medical Group Foundation. All rights reserved. August 12, 2014 Initial Feedback Report: Hypertension Prevalence and Control
Copyright © 2014 American Medical Group Foundation. All rights reserved. Agenda Quick review of measure specs Seasonality The data! ● Prevalence of hypertension ● Blood pressure control (< 140/90 mm Hg) ● Improvement 2013 Q1 → 2014 Q1 Known issues Questions on data/reporting Six Steps to Success 1
Copyright © 2014 American Medical Group Foundation. All rights reserved. John K. Cuddeback, MD PhD Chief Medical Informatics Officer 202-297-9055 (mobile) firstname.lastname@example.org 2 Rich Stempniewicz Chief Technology Officer 703-838-0033 x360 (office) email@example.com Cindy Shekailo Program Director 703-838-0033 x361 (office) firstname.lastname@example.org Nikita Stempniewicz Statistician 703-838-0033 x310 (office) email@example.com Anceta’s Measure Up/Pressure Down Data Team firstname.lastname@example.org
Copyright © 2014 American Medical Group Foundation. All rights reserved. Campaign Goal Campaign goal: 80% of patients with hypertension have their BP in control ● Originally, by JNC 7 criteria ● Current approach: < 140/90 mm Hg for all patients (NQF 0018) The percentage of patients 18 to 85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (< 140/90 mm Hg) during the measurement year. http://www.measureuppressuredown.com/Learn/Guidelines/jnc8PDF.pdf 3
Copyright © 2014 American Medical Group Foundation. All rights reserved. 4
Measurement Periods 8 40%60% Among hypertension patients seen during a 12-month period, about 60% have their last office visit during the last 3 months.
Copyright © 2014 American Medical Group Foundation. All rights reserved. Numbers to Report: Patient Counts 9 Prevalence = Denominator / Total Patients Control = Numerator / Denominator Prevalence = Denominator / Total Patients Control = Numerator / Denominator
Copyright © 2014 American Medical Group Foundation. All rights reserved. Patient Population 10 Total Patients — number of unique patients with 1 or more ambulatory E&M visits (including “prevention” services) during the 12-month reporting period, using Table CBP-B: Codes to Identify Outpatient Visits, from HEDIS® 2013 Technical Specifications for Physician Measurement: Numbers of patients are broken out by: ● Age category: 18 – 64 years, or 65 – 85 years, as of the end of the reporting period. ● By gender (male, female).
Copyright © 2014 American Medical Group Foundation. All rights reserved. Exclusions (from the Population/Denominator) Patients with unknown gender Patients with unknown age, or age 85 years, as of the end of the reporting period Patients who had an admission to a non-acute inpatient setting any time during the reporting period Patients with evidence of end-stage renal disease (ESRD) during or prior to the end of the reporting period Patients who were pregnant during the reporting period 11
Copyright © 2014 American Medical Group Foundation. All rights reserved. Denominator and Numerator 12 Denominator — number of patients in the population defined above who have a diagnosis of essential hypertension: ● on patient’s problem list, any time prior to the end of the first six months of the reporting period (rolling 12-month periods, ending each calendar quarter), or ● ICD-9-CM diagnosis code 401.XX on a claim associated with an ambulatory visit during (or before) the first six months of the reporting period, where one of the specified CPT codes is billed. Numerator — number of patients in the denominator whose last ambulatory, in-office BP during the reporting period is < 140/90 mm Hg. Note: Where multiple BP readings are recorded on a single day, take the lowest systolic reading and the lowest diastolic reading for the day. Exclusions — ● Exclude BP readings from inpatient, observation, and ER settings. (Include urgent care.) ● Exclude home BP readings and ambulatory BP monitoring data. ● Exclude BP readings taken prior to diagnosis of HTN (where feasible, examine the patient’s entire longitudinal record for the first occurrence of a 401.XX diagnosis code, or consider the date when hypertension was added to the patient’s problem list, whichever is earlier). ● Exclude from the numerator patients with no BP measurement recorded during the reporting period. Patients with no BP measurement during the reporting period are considered not in control, since they are not known to be in control.
Copyright © 2014 American Medical Group Foundation. All rights reserved. Seasonality – Data from 2012 13 Blood pressure is higher (and hypertension control is worse) during winter months (Q1 and Q4) So we’ll compare the 12 months ending 2014 Q1 to the 12 months ending 2013 Q1 Quarter (of 2012)
Copyright © 2014 American Medical Group Foundation. All rights reserved. Missing BP — Special Case NQF 0018: In general, BP not recorded is considered to be “not in control” Some groups have a few sites or providers who are not using the EHR to record BP or other clinical observations If the vast majority of the organization’s providers are using the EHR to record BP, the following are acceptable: ● Provider-level approach—If the provider for last E&M encounter during reporting period does not record clinical observations in the EHR, exclude the patient from the denominator ● Patient-level approach—If no BMI (height/weight) or other clinical observation (TPR, pain) for the patient, exclude the patient from the denominator If a substantial number of an organization’s providers are not recording clinical observations in an EHR, NCQA’s hybrid method may be used. (Please contact MU/PD data team to discuss.) 14
19 Questions on data/reporting?
Six Steps to Success Action Plan
Six Steps to Success Action Plan
Summit Medical Group Example of Success
Step 1: Give JAMA Article to All Physicians Improvement: 2001: 44% 2011: 87% Impact: Heart attacks: Declined by 24% Fatal strokes: Declined by 42% Takeaways: Create a registry Share best practices Use treatment algorithms Give patients easier-to-use medications No-cost follow-up care
Step 2: Disseminate monthly physician reports
Step 3: Re-engage all in proper BP technique
Step 4: Create a two-week follow-up process
Step 5: Adopt and promote hypertension protocols
Step 6: Use patient engagement tools
Campaign Resources MeasureUpPressureDown.com Facebook, Twitter, Flickr For Healthcare Professionals: ⁻Provider Toolkit ⁻Monthly webinars ⁻One-on-one group calls For Patients: ⁻Circulation Nation: Your Roadmap to Managing High Blood Pressure ⁻10 patient tip sheets
Azara Proprietary & Confidential Controlling High Blood Pressure 2014 Measure Changes Improving Patient Outcomes through Data.
Chronic Care Challenge Initiative. All AMGA member medical groups and health systems agreed to work together to address one of the nation’s most important.
Review Breast Cancer Screening Public Comment (CMS #125) and Discuss Controlling High Blood Pressure Measure Updates (CMS #165) Change Review Process Meeting.
Getting Blood Pressure To Goal: a Pressurized Process Grant M. Greenberg M.D., M.A., M.S.H.A.
Peter Emery, MD Specialist in Clinical Hypertension InterMed Portland, ME.
men Differences in Blood Pressure Documentation and Clinical Practice Variability: Implications for Population Management for Hypertension and Opportunities.
Series 1: Meaningful Use for Behavioral Health Providers 9/2013 From the CIHS Video Series “Ten Minutes at a Time” Module 5: Clinical Quality Measures.
HIT Standards Committee Quality Workgroup Janet Corrigan National Quality Forum June 23, 2009.
Date of download: 5/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: Renal Denervation in Moderate Treatment-Resistant.
The Cost Savings and Enhancements of a District’s Wellness Program A Case Study from Broward Presented by: Kay Blake, Training Supervisor Tina Severance-Fonte,
“Caring for our community’s health since 1973” Presented By Debra Rosen, RN, MPH Director, Quality & Health Education CCALAC Symposium All Heart Hypertension.
Blood Pressure Control 13th Annual Meeting - National Forum for Heart Disease and Stroke Prevention October 21, 2015 Cindy Ferrara, RN, MS Essentia Health.
Mental Health is Integral to Overall Health. Health Issues Related to People with Serious Mental Illness People with SMI who receive services in the public.
Albany Medical Center The Center for Health Systems Transformation.
Journal Club February 7, 2014 Sadie T. Velásquez, MD.
Free Powerpoint Templates Page 1 Using Data to Guide Improvement Presented by: Brooke Thomas, Program Advisor February 28, 2013.
Benchmark Study of Healthcare Provided by Physician Organizations funded by the California Healthcare Foundation New Directions in Managing Health Care.
CGS BILLING SERVICE
Adult Hypertension Survey Next Steps Mercy Medical Group, Inc. Alan R. Ertle, MD, MPH, MBA Monday, February 9, 2015.
Advanced Illness Management Sutter Health Lois Cross RN BSN ACM Sutter Health
OSCON – 7/27/2011 Andy Gregorowicz The MITRE Corporation © 2011 The MITRE Corporation - MITRE Public Release Case Number:
MHSPHP Metrics Forum July 2013 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection.
Impact of Recent Guidelines Recommendations on Hypertension Management Fleetwood Loustalot, Ph.D., F.N.P. Lead, Epidemiology, Surveillance and Health Services.
Underdiagnosis of Pediatric Hypertension – An Example of the Potential of Electronic Medical Record Research for Clinical Pediatricians David C Kaelber,
Section VII. Home BP Measurement 2015 Canadian Hypertension Education Program Recommendations.
Hiding in Plain Sight: Undiagnosed Hypertension Melissa Barajas Director of Population Health.
UK Renal Registry 9 th Annual Report 2006 Fig 11.1 UK transplantation prevalence rate per million population by age and gender on 31/12/2005.
Redwood Community Care Organization Data Capture for ACO Quality Measures.
Stanford Prevention Research Center STANFORD SCHOOL OF MEDICINE National Trends in the Prescribing of Anti-Hypertensive Medications Jun Ma, MD, PhD Research.
Understanding Meaningful Use Presented by: Allison Bryan MS, CHES December 7, 2012 Purdue Research Foundation 2012 Review of Stage 1 and Stage 2.
Terry McInnis, MD MPH President- Blue Thorn, Inc - Mobile Co-Chair- Center for.
Improving Clinical Processes: The Million Hearts ® Hypertension Control Change Package for Clinicians Erica K. Taylor, PhD, MPH, MA Million Hearts ® Minority.
Azara Proprietary & Confidential Overview June 2014 Improving Patient Outcomes through Data.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
By phone: 1) Dial ) Enter conference ID: # Join the audio conference: Via internet: 1) Click the phone icon 2) Click “Connect”
CKD in the United States: An Overview of USRDS Annual Data Report Volume ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
The TRial Of Preventing HYpertension (TROPHY) TROPHY.
Monthly Metrics Forum February 2014 Appropriate Testing for Children With Pharyngitis And Appropriate Treatment for Children With Upper Respiratory Infection.
EHRS as a Tool to Improve BP Control 1.Brief history of OQIUN, CCI. Began 1999 using data cards. Started working with multiple practice sites using different.
CARDIOVASCULAR DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
Copyright © 2015 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 6 Clinical Use of the Electronic Health Record.
Setting: The Department of Veterans Affairs Myrtle Beach Community Based outpatient Clinic (CBOC) offers Primary Care services to more than 10,000 veterans,
Hypertension & diabetes: new guidelines Janice Douglas, MD Case Western University Cleveland, OH George L Bakris, MD Director of the Hypertension/Clinical.
2 nd Thursday of the Month MHSPHP Metrics Forum Asthma September 2013
Measuring the Occurrence of Disease 1 Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State.
The Effect of Quality Improvement on Racial Disparities in Diabetes Care Thomas D. Sequist, MD MPH Alyce S. Adams, PhD Fang Zhang, MS Dennis Ross-Degnan,
Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.
© 2014 The Permanente Medical Group, Inc. All Rights Reserved. The Permanente Medical Group AMGA Acclaim Award recipient, 2013 Transforming Health Care.
GO! Diabetes Train the Trainer Program. Practice Performance and Improvement.
© 2017 SlidePlayer.com Inc. All rights reserved.